Celebrex Branded DTC Campaign Launches In 50 Publications
Executive Summary
Searle/Pfizer's first branded direct-to-consumer ad campaign for the COX-2 inhibitor Celebrex will run in approximately 50 publications after its Sept. 8 launch.
You may also be interested in...
Senate Hearings On IoM Medical Errors Report Planned For Early 2000
Senate Labor/HHS Appropriations Subcommittee Chairman Specter (R-Penn.) is planning a hearing to discuss recommendations outlined in a Nov. 29 Institute of Medicine report on medical errors and patient safety.
Senate Hearings On IoM Medical Errors Report Planned For Early 2000
Senate Labor/HHS Appropriations Subcommittee Chairman Specter (R-Penn.) is planning a hearing to discuss recommendations outlined in a Nov. 29 Institute of Medicine report on medical errors and patient safety.
Searle/Pfizer Celebrex
Celecoxib NDA for treatment of familial adenomatous polyposis will receive six-month priority review; new indication for the COX-2 inhibitor was submitted as early as the last week in June